Bayer seeks veterinary, industry backing before Baytril hearing.
D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002645:Chickens; D024881:Drug Resistance, Bacterial; D004335:Drug and Narcotic Control; D000077422:Enrofloxacin; D024841:Fluoroquinolones; D011201:Poultry Diseases / Q000188:drug therapy*; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D000077422:Enrofloxacin